Free Trial

Humacyte (HUMA) Short Interest Ratio & Short Volume

Humacyte logo
$1.44 -0.02 (-1.03%)
As of 02:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Humacyte Short Interest Data

Humacyte (HUMA) has a short interest of 26.09 million shares, representing 20.75% of the float (the number of shares available for trading by the public). This marks a -3.87% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.5, indicating that it would take 7.5 days of the average trading volume of 3.57 million shares to cover all short positions.

Current Short Interest
26,090,000 shares
Previous Short Interest
27,140,000 shares
Change Vs. Previous Month
-3.87%
Dollar Volume Sold Short
$40.18 million
Short Interest Ratio
7.5 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
155,119,000 shares
Float Size
125,750,000 shares
Short Percent of Float
20.75%
Today's Trading Volume
759,109 shares
Average Trading Volume
3,573,632 shares
Today's Volume Vs. Average
21%
Short Selling Humacyte?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Humacyte and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HUMA Short Interest Over Time

HUMA Days to Cover Over Time

HUMA Percentage of Float Shorted Over Time

Humacyte Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202526,090,000 shares $40.18 million -3.9%20.8%7.5 $1.54
3/31/202527,140,000 shares $46.27 million +2.0%21.6%7.9 $1.71
3/15/202526,600,000 shares $80.86 million +4.4%25.5%6.8 $3.04
2/28/202525,480,000 shares $86.63 million +5.8%24.4%6.4 $3.40
2/15/202524,080,000 shares $94.15 million +0.2%23.1%6 $3.91
1/31/202524,040,000 shares $110.10 million -6.2%23.0%5.6 $4.58
1/15/202525,640,000 shares $117.43 million -13.4%24.6%5.7 $4.58
12/31/202429,620,000 shares $149.58 million +34.9%28.4%6.3 $5.05
12/15/202421,960,000 shares $90.04 million +8.0%21.0%5 $4.10
11/30/202420,330,000 shares $91.89 million +6.2%19.6%6.7 $4.52
11/15/202419,140,000 shares $92.54 million +11.0%18.5%6.3 $4.84
10/31/202417,250,000 shares $87.11 million +3.4%17.6%5.8 $5.05
10/15/202416,680,000 shares $95.08 million +4.1%17.0%5.5 $5.70
9/30/202416,030,000 shares $87.20 million +14.4%16.4%5.1 $5.44
9/15/202414,010,000 shares $79.02 million +24.3%15.0%4.3 $5.64
8/31/202411,270,000 shares $68.18 million -1.2%12.1%3.4 $6.05
8/15/202411,410,000 shares $70.06 million -5.0%12.4%3.3 $6.14
7/31/202412,010,000 shares $113.61 million -17.7%13.1%3.5 $9.46
7/15/202414,600,000 shares $122.64 million +77.0%15.9%4.8 $8.40
6/30/20248,250,000 shares $39.60 million +58.7%9.0%3 $4.80
6/15/20245,200,000 shares $36.66 million +5.9%5.7%2.2 $7.05
5/31/20244,910,000 shares $36.73 million +17.2%5.4%2.4 $7.48
5/15/20244,190,000 shares $27.11 million -6.7%4.6%2.4 $6.47
4/30/20244,490,000 shares $17.60 million +14.0%5.0%3.2 $3.92
4/15/20243,940,000 shares $11.31 million -1.0%4.4%3 $2.87
3/31/20243,980,000 shares $12.38 million +5.3%4.6%4.1 $3.11
3/15/20243,780,000 shares $12.25 million -36.5%4.5%4.3 $3.24
2/29/20245,950,000 shares $25.88 million -9.3%7.0%7.6 $4.35
2/15/20246,560,000 shares $29.26 million +7.0%8.8%12 $4.46
1/31/20246,130,000 shares $20.35 million No Change8.2%13 $3.32
1/15/20246,130,000 shares $16.24 million +1.7%8.2%13.7 $2.65
12/31/20236,030,000 shares $17.13 million +8.5%8.1%13.2 $2.84
12/15/20235,560,000 shares $17.18 million -5.3%7.4%12.4 $3.09
11/30/20235,870,000 shares $15.56 million -3.6%7.8%10.9 $2.65
11/15/20236,090,000 shares $15.23 million +10.7%8.1%10.4 $2.50
10/31/20235,500,000 shares $11.66 million +7.8%7.4%7.7 $2.12
10/15/20235,100,000 shares $13.16 million -4.3%6.8%7.7 $2.58
9/30/20235,330,000 shares $15.62 million +1.5%7.1%8.3 $2.93
9/15/20235,250,000 shares $16.98 million +38.2%7.0%7.8 $3.24
8/31/20233,800,000 shares $14.55 million +19.1%5.7%5.5 $3.83
Trump announcement boosts “next Bitcoin” (Ad)

President Trump just made his first big crypto move ... Announcing the creation of a national strategic reserve for Bitcoin and Ethereum. But there's something else going on here …

To learn more about this next Bitcoin — click here before another proclamation by Trump sends the pr
8/15/20233,190,000 shares $14.29 million +6.3%4.9%5.1 $4.48
7/31/20233,000,000 shares $9.84 million No Change4.7%6.3 $3.28
7/15/20233,000,000 shares $9.09 million +2.4%4.7%6.6 $3.03
6/30/20232,930,000 shares $8.38 million -1.7%4.5%6.7 $2.86
6/15/20232,980,000 shares $9.98 million -31.0%5.4%7.8 $3.35
5/31/20234,320,000 shares $14.82 million -21.7%7.6%15.7 $3.43
5/15/20235,520,000 shares $22.00 million +5.8%10.2%21 $3.99
4/30/20235,220,000 shares $16.91 million +0.2%9.7%21.9 $3.24
4/15/20235,210,000 shares $16.93 million -1.0%9.6%23.2 $3.25
3/31/20235,260,000 shares $16.25 million +3.3%9.7%22.6 $3.09
3/15/20235,090,000 shares $14.51 million +2.2%9.4%19 $2.85
2/28/20234,980,000 shares $15.24 million +3.5%9.8%14.7 $3.06
2/15/20234,810,000 shares $15.34 million +7.1%9.4%14.5 $3.19
1/31/20234,490,000 shares $11.81 million +3.0%8.8%13 $2.63
1/15/20234,360,000 shares $10.90 million -4.2%8.6%11.8 $2.50
12/30/20224,550,000 shares $9.60 million +1.6%8.9%11.7 $2.11
12/15/20224,480,000 shares $11.65 million +1.8%8.6%11.4 $2.60
11/30/20224,400,000 shares $13.73 million -4.4%8.5%12.7 $3.12
11/15/20224,600,000 shares $13.66 million -19.3%8.9%12.6 $2.97
10/31/20225,700,000 shares $19.61 million -13.6%11.0%13.8 $3.44
10/15/20226,600,000 shares $20.79 million -17.7%12.7%16.5 $3.15
9/30/20228,020,000 shares $26.15 million +2.0%15.5%19.8 $3.26
9/15/20227,860,000 shares $32.15 million -6.5%15.2%18.1 $4.09
8/31/20228,410,000 shares $30.70 million -5.9%16.7%20.1 $3.65
8/15/20228,940,000 shares $42.73 million +2.6%17.7%19.1 $4.78
7/31/20228,710,000 shares $30.31 million +5.5%17.3%19.7 $3.48
7/15/20228,260,000 shares $28.91 million +10.0%16.4%18.2 $3.50
6/30/20227,510,000 shares $24.11 million +1.6%14.9%16.4 $3.21
6/15/20227,390,000 shares $27.93 million -2.1%14.7%16.3 $3.78
5/31/20227,550,000 shares $41.00 million +21.2%15.0%18.2 $5.43
5/15/20226,230,000 shares $33.46 million +5.8%12.3%16.8 $5.37
4/30/20225,890,000 shares $41.70 million +3.9%11.7%17.4 $7.08
4/15/20225,670,000 shares $41.79 million +15.2%11.2%15.8 $7.37
3/31/20224,920,000 shares $34.74 million +11.6%9.8%12.1 $7.06
3/15/20224,410,000 shares $25.00 million +10.3%8.7%9.9 $5.67
2/28/20224,000,000 shares $24.12 million +0.5%7.9%7.6 $6.03
2/15/20223,980,000 shares $23.04 million +14.7%7.9%7.3 $5.79
1/31/20223,470,000 shares $18.67 million +17.2%7.1%6.1 $5.38
1/15/20222,960,000 shares $17.26 million +21.3%N/A0 $5.83
12/31/20212,440,000 shares $17.69 million No Change5.0%4.1 $7.25

HUMA Short Interest - Frequently Asked Questions

What is Humacyte's current short interest?

Short interest is the volume of Humacyte shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 26,090,000 shares of HUMA short. 20.75% of Humacyte's shares are currently sold short. Learn More on Humacyte's current short interest.

What is a good short interest ratio for Humacyte?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HUMA shares currently have a short interest ratio of 8.0. Learn More on Humacyte's short interest ratio.

Which institutional investors are shorting Humacyte?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Humacyte: Wolverine Trading LLC, Group One Trading LLC, Citadel Advisors LLC, Jane Street Group LLC, and Susquehanna International Group LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Humacyte?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.75% of Humacyte's floating shares are currently sold short.

Is Humacyte's short interest increasing or decreasing?

Humacyte saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 26,090,000 shares, a decline of 3.9% from the previous total of 27,140,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Humacyte's float size?

Humacyte currently has issued a total of 155,119,000 shares. Some of Humacyte's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Humacyte currently has a public float of 125,750,000 shares.

How does Humacyte's short interest compare to its competitors?

20.75% of Humacyte's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Humacyte: Pharvaris (3.20%), Spyre Therapeutics, Inc. (22.97%), Mineralys Therapeutics, Inc. (15.91%), Intellia Therapeutics, Inc. (28.92%), Nurix Therapeutics, Inc. (20.43%), Gyre Therapeutics, Inc. (14.16%), Arcus Biosciences, Inc. (14.86%), Collegium Pharmaceutical, Inc. (14.46%), Avadel Pharmaceuticals plc (10.21%), Vir Biotechnology, Inc. (11.55%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Humacyte stock?

Short selling HUMA is an investing strategy that aims to generate trading profit from Humacyte as its price is falling. HUMA shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Humacyte?

A short squeeze for Humacyte occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HUMA, which in turn drives the price of the stock up even further.

How often is Humacyte's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HUMA, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:HUMA) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners